RHOJ controls EMT-associated resistance to chemotherapy.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
19
09
2021
accepted:
14
02
2023
medline:
7
4
2023
pubmed:
24
3
2023
entrez:
23
3
2023
Statut:
ppublish
Résumé
The resistance of cancer cells to therapy is responsible for the death of most patients with cancer
Identifiants
pubmed: 36949199
doi: 10.1038/s41586-023-05838-7
pii: 10.1038/s41586-023-05838-7
pmc: PMC10076223
doi:
Substances chimiques
Actins
0
rho GTP-Binding Proteins
EC 3.6.5.2
Rhoj protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
168-175Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2023. The Author(s).
Références
Zaorsky, N. G. et al. Causes of death among cancer patients. Ann. Oncol. 28, 400–407 (2017).
pubmed: 27831506
doi: 10.1093/annonc/mdw604
Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128–134 (2018).
pubmed: 29326430
doi: 10.1038/nrc.2017.118
Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611–629 (2017).
pubmed: 28397828
pmcid: 5720366
doi: 10.1038/nrclinonc.2017.44
Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21–45 (2016).
pubmed: 27368099
doi: 10.1016/j.cell.2016.06.028
Puisieux, A., Brabletz, T. & Caramel, J. Oncogenic roles of EMT-inducing transcription factors. Nat. Cell Biol. 16, 488–494 (2014).
pubmed: 24875735
doi: 10.1038/ncb2976
Li, Q. Q. et al. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin. Cancer Res. 15, 2657–2665 (2009).
pubmed: 19336515
doi: 10.1158/1078-0432.CCR-08-2372
Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16, 864–875 (2014).
pubmed: 25086746
pmcid: 4150825
doi: 10.1038/ncb3013
Zheng, X. et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525–530 (2015).
pubmed: 26560028
pmcid: 4849281
doi: 10.1038/nature16064
Fischer, K. R. et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472–476 (2015).
pubmed: 26560033
pmcid: 4662610
doi: 10.1038/nature15748
Latil, M. et al. Cell-type-specific chromatin states differentially prime squamous cell carcinoma tumor-initiating cells for epithelial to mesenchymal transition. Cell Stem Cell 20, 191–204 (2017).
pubmed: 27889319
doi: 10.1016/j.stem.2016.10.018
Schmults, C. D. et al. NCCN Guidelines® insights: squamous cell skin cancer, Version 1.2022. J. Natl Compr. Canc. Netw. 19, 1382–1394 (2021).
pubmed: 34902824
doi: 10.6004/jnccn.2021.0059
Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463–468 (2018).
pubmed: 29670281
doi: 10.1038/s41586-018-0040-3
Ho, H. et al. RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damage. Cancer Res. 72, 5516–5528 (2012).
pubmed: 22971344
pmcid: 3548429
doi: 10.1158/0008-5472.CAN-12-0775
Ruiz, R. et al. The RhoJ-BAD signaling network: an Achilles’ heel for BRAF mutant melanomas. PLoS Genet. 13, e1006913 (2017).
pubmed: 28753606
pmcid: 5549996
doi: 10.1371/journal.pgen.1006913
Chen, B. et al. MKL1 mediates TGF-β induced RhoJ transcription to promote breast cancer cell migration and invasion. Front Cell Dev. Biol. 8, 832 (2020).
pubmed: 32984327
pmcid: 7478007
doi: 10.3389/fcell.2020.00832
Kaur, S. et al. RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers. Arterioscler. Thromb. Vasc. Biol. 31, 657–664 (2011).
pubmed: 21148427
doi: 10.1161/ATVBAHA.110.216341
Wang, M. et al. Rhoj is a novel target for progression and invasion of glioblastoma by impairing cytoskeleton dynamics. Neurotherapeutics 17, 2028–2040 (2020).
pubmed: 32822001
pmcid: 7851251
doi: 10.1007/s13311-020-00910-w
Polo, S. E. & Jackson, S. P. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409–433 (2011).
pubmed: 21363960
pmcid: 3049283
doi: 10.1101/gad.2021311
Vignal, E. et al. Characterization of TCL, a new GTPase of the rho family related to TC10 and Cdc42. J. Biol. Chem. 275, 36457–36464 (2000).
pubmed: 10967094
doi: 10.1074/jbc.M003487200
Higgs, M. R. et al. BOD1L is required to suppress deleterious resection of stressed replication forks. Mol. Cell 59, 462–477 (2015).
pubmed: 26166705
doi: 10.1016/j.molcel.2015.06.007
Bagci, H. et al. Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms. Nat. Cell Biol. 22, 120–134 (2020).
pubmed: 31871319
doi: 10.1038/s41556-019-0438-7
Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801–817 (2017).
pubmed: 28622525
doi: 10.1016/j.molcel.2017.05.015
Schultz, L. B., Chehab, N. H., Malikzay, A. & Halazonetis, T. D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381–1390 (2000).
pubmed: 11134068
pmcid: 2150674
doi: 10.1083/jcb.151.7.1381
Chapman, J. R. et al. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 49, 858–871 (2013).
pubmed: 23333305
pmcid: 3594748
doi: 10.1016/j.molcel.2013.01.002
Liu, J. S., Kuo, S. R. & Melendy, T. DNA damage-induced RPA focalization is independent of gamma-H2AX and RPA hyper-phosphorylation. J. Cell. Biochem. 99, 1452–1462 (2006).
pubmed: 16927366
doi: 10.1002/jcb.21066
Murai, J. et al. SLFN11 blocks stressed replication forks independently of ATR. Mol. Cell 69, 371–384 (2018).
pubmed: 29395061
pmcid: 5802881
doi: 10.1016/j.molcel.2018.01.012
Petermann, E., Orta, M. L., Issaeva, N., Schultz, N. & Helleday, T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37, 492–502 (2010).
pubmed: 20188668
pmcid: 2958316
doi: 10.1016/j.molcel.2010.01.021
Cybulla, E. & Vindigni, A. Leveraging the replication stress response to optimize cancer therapy. Nat. Rev. Cancer 23, 6–24 (2023).
pubmed: 36323800
doi: 10.1038/s41568-022-00518-6
Cimprich, K. A. & Cortez, D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9, 616–627 (2008).
pubmed: 18594563
pmcid: 2663384
doi: 10.1038/nrm2450
Byun, T. S., Pacek, M., Yee, M. C., Walter, J. C. & Cimprich, K. A. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev. 19, 1040–1052 (2005).
pubmed: 15833913
pmcid: 1091739
doi: 10.1101/gad.1301205
Tye, S., Ronson, G. E. & Morris, J. R. A fork in the road: where homologous recombination and stalled replication fork protection part ways. Semin. Cell Dev. Biol. 113, 14–26 (2020).
Técher, H. et al. Replication dynamics: biases and robustness of DNA fiber analysis. J. Mol. Biol. 425, 4845–4855 (2013).
pubmed: 23557832
doi: 10.1016/j.jmb.2013.03.040
Ge, X. Q., Jackson, D. A. & Blow, J. J. Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress. Genes Dev. 21, 3331–3341 (2007).
pubmed: 18079179
pmcid: 2113033
doi: 10.1101/gad.457807
Ibarra, A., Schwob, E. & Méndez, J. Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc. Natl Acad. Sci. USA 105, 8956–8961 (2008).
pubmed: 18579778
pmcid: 2449346
doi: 10.1073/pnas.0803978105
Dopie, J., Skarp, K. P., Rajakylä, E. K., Tanhuanpää, K. & Vartiainen, M. K. Active maintenance of nuclear actin by importin 9 supports transcription. Proc. Natl Acad. Sci. USA 109, E544–E552 (2012).
pubmed: 22323606
pmcid: 3295300
doi: 10.1073/pnas.1118880109
Andrin, C. et al. A requirement for polymerized actin in DNA double-strand break repair. Nucleus 3, 384–395 (2012).
pubmed: 22688650
doi: 10.4161/nucl.21055
Belin, B. J., Lee, T. & Mullins, R. D. DNA damage induces nuclear actin filament assembly by formin-2 and spire-1/2 that promotes efficient DNA repair. eLlife 4, e07735 (2015).
doi: 10.7554/eLife.07735
Caridi, C. P. et al. Nuclear F-actin and myosins drive relocalization of heterochromatic breaks. Nature 559, 54–60 (2018).
pubmed: 29925946
pmcid: 6051730
doi: 10.1038/s41586-018-0242-8
Lamm, N. et al. Nuclear F-actin counteracts nuclear deformation and promotes fork repair during replication stress. Nat. Cell Biol. 22, 1460–1470 (2020).
pubmed: 33257806
doi: 10.1038/s41556-020-00605-6
Parisis, N. et al. Initiation of DNA replication requires actin dynamics and formin activity. EMBO J. 36, 3212–3231 (2017).
pubmed: 28982779
pmcid: 5666611
doi: 10.15252/embj.201796585
Schrank, B. R. et al. Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559, 61–66 (2018).
pubmed: 29925947
pmcid: 6145447
doi: 10.1038/s41586-018-0237-5
Lionarons, D. A. et al. RAC1
pubmed: 31257073
pmcid: 6617390
doi: 10.1016/j.ccell.2019.05.015
Magalhaes, Y. T., Silva, G. E. T., Osaki, J. H., Rocha, C. R. R. & Forti, F. L. RHOAming through the nucleotide excision repair pathway as a mechanism of cellular response against the effects of UV radiation. Front. Cell Dev. Biol. 8, 816 (2020).
pubmed: 33015036
pmcid: 7509447
doi: 10.3389/fcell.2020.00816
Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014).
pubmed: 24556840
pmcid: 4240281
doi: 10.1038/nrm3758
Ho, H. et al. RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics. Pigment Cell Melanoma Res. 26, 218–225 (2013).
pubmed: 23253891
pmcid: 4528913
doi: 10.1111/pcmr.12058
Abe, T., Kato, M., Miki, H., Takenawa, T. & Endo, T. Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth. J. Cell Sci. 116, 155–168 (2003).
pubmed: 12456725
doi: 10.1242/jcs.00208
Aymard, F. et al. Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genes. Nat. Struct. Mol. Biol. 24, 353–361 (2017).
pubmed: 28263325
pmcid: 5385132
doi: 10.1038/nsmb.3387
Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
pubmed: 11299042
pmcid: 31338
doi: 10.1186/1471-213X-1-4
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
pubmed: 20023653
doi: 10.1038/nn.2467
Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007 (2007).
pubmed: 17934449
doi: 10.1038/nature06196
Tuveson, D. A. et al. Endogenous oncogenic K-ras
pubmed: 15093544
doi: 10.1016/S1535-6108(04)00085-6
Lapouge, G. et al. Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. EMBO J. 31, 4563–4575 (2012).
pubmed: 23188079
pmcid: 3545290
doi: 10.1038/emboj.2012.312
Kim, C. et al. Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption. Cancer Cell 25, 102–117 (2014).
pubmed: 24434213
doi: 10.1016/j.ccr.2013.12.010
Lapouge, G. et al. Identifying the cellular origin of squamous skin tumors. Proc. Natl Acad. Sci. USA 108, 7431–7436 (2011).
pubmed: 21502497
pmcid: 3088632
doi: 10.1073/pnas.1012720108
Sambrook, J. & Russell, D. W. Identification of associated proteins by coimmunoprecipitation. CSH Protoc. 2006, pdb.prot3898 (2006).
pubmed: 22485357
Coulonval, K. et al. Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. Cell Cycle 21, 12–32 (2022).
pubmed: 34913830
doi: 10.1080/15384101.2021.1984663
Rodriguez-Acebes, S., Mourón, S. & Méndez, J. Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes. J. Biol. Chem. 293, 12855–12861 (2018).
pubmed: 29959228
pmcid: 6102153
doi: 10.1074/jbc.RA118.003740
Mourón, S. et al. Repriming of DNA synthesis at stalled replication forks by human PrimPol. Nat. Struct. Mol. Biol. 20, 1383–1389 (2013).
pubmed: 24240614
doi: 10.1038/nsmb.2719
Jackson, D. A. & Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J. Cell Biol. 140, 1285–1295 (1998).
pubmed: 9508763
pmcid: 2132671
doi: 10.1083/jcb.140.6.1285
Petermann, E., Woodcock, M. & Helleday, T. Chk1 promotes replication fork progression by controlling replication initiation. Proc. Natl Acad. Sci. USA 107, 16090–16095 (2010).
pubmed: 20805465
pmcid: 2941317
doi: 10.1073/pnas.1005031107
Méndez, J. & Stillman, B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20, 8602–8612 (2000).
pubmed: 11046155
pmcid: 102165
doi: 10.1128/MCB.20.22.8602-8612.2000
Chiva, C. et al. QCloud: a cloud-based quality control system for mass spectrometry-based proteomics laboratories. PLoS ONE 13, e0189209 (2018).
pubmed: 29324744
pmcid: 5764250
doi: 10.1371/journal.pone.0189209
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
pubmed: 30395289
doi: 10.1093/nar/gky1106
Zhang, X. et al. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat. Protoc. 13, 530–550 (2018).
pubmed: 29446774
doi: 10.1038/nprot.2017.147
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792
pmcid: 4402510
doi: 10.1093/nar/gkv007